Martin Rowlands

4.0k total citations
67 papers, 2.6k citations indexed

About

Martin Rowlands is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Martin Rowlands has authored 67 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 21 papers in Genetics and 16 papers in Organic Chemistry. Recurrent topics in Martin Rowlands's work include Estrogen and related hormone effects (20 papers), Heat shock proteins research (11 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Martin Rowlands is often cited by papers focused on Estrogen and related hormone effects (20 papers), Heat shock proteins research (11 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Martin Rowlands collaborates with scholars based in United Kingdom, Belgium and Switzerland. Martin Rowlands's co-authors include Michael Jarman, S. Elaine Barrie, Gerard A. Potter, Paul Workman, Wynne Aherne, Laurence H. Pearl, Raymond McCague, Chrisostomos Prodromou, Andrew Pelter and G. Wynne Aherne and has published in prestigious journals such as The EMBO Journal, Cancer Research and Analytical Biochemistry.

In The Last Decade

Martin Rowlands

67 papers receiving 2.5k citations

Peers

Countries citing papers authored by Martin Rowlands

Since Specialization

Citations

This map shows the geographic impact of Martin Rowlands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Rowlands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Rowlands more than expected).

Fields of papers citing papers by Martin Rowlands

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Rowlands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Rowlands. The network helps show where Martin Rowlands may publish in the future.

Co-authorship network of co-authors of Martin Rowlands

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Rowlands. A scholar is included among the top collaborators of Martin Rowlands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Rowlands. Martin Rowlands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes 2023 ·Journal of Medicinal Chemistry ·(unknown), Thomas P. Matthews, (unknown), (unknown), Tatiana McHardy, Giampiero Colombano, (unknown), Martin Rowlands, (unknown), Craig McAndrew, (unknown), Delphine Guillotin, Grace Wing-Yan Mak, Κωνσταντίνος Δροσόπουλος, (unknown), Rosemary Burke, Rob van Montfort, Spiros Linardopoulos, Ian Collins	3
2	Privileged Structures and Polypharmacology within and between Protein Families 2018 ·ACS Medicinal Chemistry Letters ·Joshua Meyers, N. Chessum, (unknown), N. Yi Mok, Birgit Wilding, (unknown), Martin Rowlands, Michael Tucker, Lindsay E. Evans, Carl S. Rye, (unknown), Yann‐Vaï Le Bihan, Rosemary Burke, Michael D. Carter, Paul Workman, Julian Blagg, Nathan Brown, Rob L. M. van Montfort, Keith Jones, Matthew D. Cheeseman	12
3	Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766) 2017 ·Journal of Medicinal Chemistry ·N. Chessum, Swee Y. Sharp, John Caldwell, (unknown), Birgit Wilding, Giampiero Colombano, Ian Collins, Buğra Özer, (unknown), Martin Rowlands, Mark Stubbs, Rosemary Burke, Craig McAndrew, Paul A. Clarke, Paul Workman, Matthew D. Cheeseman, Keith Jones	74
4	Inhibition of Hsp90 with Resorcylic Acid Macrolactones: Synthesis and Binding Studies 2010 ·Chemistry - A European Journal ·James E. H. Day, Swee Y. Sharp, Martin Rowlands, Wynne Aherne, William Lewis, S. Mark Roe, Chrisostomos Prodromou, Laurence H. Pearl, Paul Workman, Christopher J. Moody	21
5	Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B 2005 ·Bioorganic & Medicinal Chemistry ·Ian Collins, John Caldwell, (unknown), Alastair Donald, Vassilios Bavetsias, (unknown), Michelle D. Garrett, Martin Rowlands, G. Wynne Aherne, Thomas G. Davies, Valério Berdini, Steven J. Woodhead, Deborah Davis, Lisa C. A. Seavers, Paul G. Wyatt, Paul Workman, Edward McDonald	31
6	Mechanism of action of a novel series of inhibitors of the Hsp90 molecular chaperone 2004 ·Cancer Research ·Swee Y. Sharp, Alison Maloney, Paul A. Clarke, Wynne Aherne, Suzanne A. Eccles, Kathy Boxall, Martin Rowlands, Florence I. Raynaud, Bernard Nutley, Nicola F. Smith, Angela Hayes, Anthea Hardcastle, Laurence H. Pearl, (unknown), (unknown), (unknown), Thomas P. Matthews, (unknown), Martin J. Drysdale, Paul Workman	1
7	High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity 2004 ·Analytical Biochemistry ·Martin Rowlands, Yvette Newbatt, Chrisostomos Prodromou, Laurence H. Pearl, Paul Workman, Wynne Aherne	158
8	Assays for HSP90 and Inhibitors 2003 ·Humana Press eBooks ·Wynne Aherne, Alison Maloney, Chrisostomos Prodromou, Martin Rowlands, Anthea Hardcastle, K. Boxall, Paul A. Clarke, Michael I. Walton, Laurence H. Pearl	23
9	Solid-phase synthesis of novel inhibitors of Farnesyl Transferase 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Ian R. Hardcastle, Martin Rowlands, Bernard Nutley, (unknown), Michael Jarman	17
10	Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer 1995 ·Journal of Medicinal Chemistry ·Gerard A. Potter, S. Elaine Barrie, Michael Jarman, Martin Rowlands	293
11	Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues 1994 ·Biochemical Pharmacology ·Raymond McCague, Martin Rowlands, Rachel Grimshaw, Michael Jarman	10
12	Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer 1993 ·The Journal of Steroid Biochemistry and Molecular Biology ·T.R. Jeffry Evans, Martin Rowlands, (unknown), Matthew Law, R. Charles Coombes	30
13	Conformational analysis of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (rogletimide) and discovery of potent 5-alkyl derivatives 1992 ·Journal of Medicinal Chemistry ·Raymond McCague, Martin Rowlands	10
14	Effects of 4-Hydroxyandrost-4-Ene-3,17-Dione and Its Metabolites on 5α-Reductase Activity and the Androgen Receptor 1992 ·Journal of enzyme inhibition ·(unknown), Robert Shearer, Martin Rowlands, Grace K. Poon, John Houghton, Michael Jarman, Mitch Dowsett	10
15	Inhibition of estrone sulfatase enzyme in human placenta and human breast carcinoma 1991 ·The Journal of Steroid Biochemistry and Molecular Biology ·T.R. Jeffry Evans, Martin Rowlands, Michael Jarman, R. Charles Coombes	40
16	Comparison of Aromatase Activity in Human Prostatic, Testicular and Placental Tissues 1991 ·Journal of enzyme inhibition ·Martin Rowlands, John Davies, Robert Shearer, Mitch Dowsett	8
17	Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analog, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives 1990 ·Journal of Medicinal Chemistry ·Charles A. Laughton, (unknown), Stephen Neidle, Michael Jarman, R. MCCAGUE, Martin Rowlands	19
18	Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicity 1990 ·Biochemical Pharmacology ·Martin Rowlands, Iris B. Parr, Raymond McCague, Michael Jarman, Phyllis M. Goddard	70
19	Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid 1990 ·Journal of Medicinal Chemistry ·Raymond McCague, Martin Rowlands, S. Elaine Barrie, John Houghton	52
20	Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors 1987 ·Steroids ·Martin Rowlands, A. B. Foster, John Mann, (unknown), (unknown), R. Charles Coombes	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact